Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

522 trials

2024-518937-26-00
Recruiting
Efficacy and safety of the combination of Cisplatin plus Nab-paclitaxel and Nivolumab with radiotherapy after maximal tumor resection in non-metastatic muscle invasive Bladder Cancer. (CA209-6E8, CNN-BC trial)
Phase 2 · Italy · 9 sites
Registry update: 23 Jul 2026
NCT05679557
Recruiting
Comprehensive Geriatric Assessment for Perioperative Optimization in Cystectomy
Not applicable · Denmark · 1 site
Registry update: 27 Feb 2026
NCT05649306
Recruiting
Gender Related Coping and Survivorship for Genitourinary Cancers
Not applicable · United States · 2 sites
Registry update: 29 Oct 2026
NCT05614739
Recruiting
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Phase 1 · Australia, Canada, China, Germany, Spain, France, United Kingdom, Israel, Italy, Japan, South Korea, Netherlands, Norway, United States · 83 sites
Registry update: 4 Nov 2026
NCT05519878
Recruiting
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
Not applicable · United States · 1 site
Registry update: 19 Oct 2026
NCT05592626
Recruiting
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Phase 1/2 · Canada, Spain, France, United States · 19 sites
Registry update: 11 Aug 2026
NCT05837806
Recruiting
Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therapy for HER2-positive High-risk Upper Tract Urothelial Carcinoma (UTUC)
Phase 2 · China · 1 site
Registry update: 14 Jul 2026
NCT04625556
Recruiting
Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome
Not applicable · South Korea · 1 site
Registry update: 31 Jan 2023
NCT05600127
Recruiting
Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer
Phase 2 · Netherlands · 4 sites
Registry update: 8 Sept 2023
NCT05410730
Recruiting
A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC
Phase 1/2 · China · 1 site
Registry update: 28 Jan 2025
NCT05917158
Recruiting
A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma
Phase 2 · China · 1 site
Registry update: 22 Jan 2025
NCT04923178
Recruiting
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
Not applicable · United States · 1 site
Registry update: 16 Oct 2026
NCT05519241
Recruiting
A Phase I Intravesical PPM Therapy for NMIBC
Phase 1 · United States · 1 site
Registry update: 17 Aug 2026
NCT05562791
Recruiting
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
Phase 1 · United States · 7 sites
Registry update: 22 Apr 2026
NCT05464576
Recruiting
Tumor Staging T of Bladder Tumours: Correlation of MRI and Anatomopathologic Analysis
Not applicable · France · 1 site
Registry update: 16 Sept 2026
NCT04916990
Recruiting
Improving Care for Rural Patients With Solid Tumors
Not applicable · United States · 14 sites
Registry update: 5 Feb 2026
NCT05334069
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Not applicable · United States · 751 sites
Registry update: 4 Nov 2026
NCT06732531
Recruiting
Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer
Phase 1/2 · China · 6 sites
Registry update: 9 Jan 2025
NCT06109857
Recruiting
Bladder Bank (a Prospective Banking Study)
Not applicable · United States · 1 site
Registry update: 14 Oct 2026
NCT05312671
Recruiting
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Phase 2 · United States · 2 sites
Registry update: 25 Jun 2026

Ordered by registry start date. Freshness and sponsorship never change the order.